Recent guidance from the Ohio Board of Pharmacy (BOP) indicates that providers should generally use the FDA approved GLP-1 drug, rather than a non-FDA approved compounded version of the medication
Over the following months, results continue to build
Large e-commerce platforms, cross-border marketplaces, and direct-to-consumer brands boost access to liposomal glutathione and citrulline endurance blends
Studies show people lose an average of 15% of their body weight with injectable semaglutide and an average of 21% with tirzepatide
We recommend Ro for a lot of things, but weight loss isnt one of them at this time
Maggy Donaldson, Agence France-Presse Published July 24, 2026 10:14 AM PHT ABS-CBN Newsletter Your go-to source for the latest news, entertainment highlights, exclusive interviews, and updates on your favorite Kapamilya stars